Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel R Kuritzkes

Showing results (1-10 of 280) with videos related to

Pageof 28
Sort By:
Current Opinion in Virology|December 14, 2011
Drug resistance in HIV-1Daniel R Kuritzkes
AIDS (London, England)|August 24, 2004
Extending antiretroviral therapy to resource-poor settings: implications for drug resistanceDaniel R Kuritzkes
Current Opinion in HIV and AIDS|April 3, 2009
HIV-1 entry inhibitors: an overviewDaniel R Kuritzkes
Journal of Medical Ethics|June 9, 2016
Why cure, why now?Daniel R Kuritzkes
The AIDS Reader|December 8, 2009
Effect of antiretroviral resistance on response in treatment-experienced patientsDaniel R Kuritzkes
Topics in HIV Medicine : a Publication of the International AIDS Society, USA|December 13, 2007
HIV resistance: frequency, testing, mechanismsDaniel R Kuritzkes
Current Opinion in HIV and AIDS|June 2, 2023
Broadly neutralizing antibodies and long-acting antiretroviral drugs as treatments for HIVDaniel R Kuritzkes
AIDS Patient Care and Stds|June 10, 2004
Preventing and managing antiretroviral drug resistanceDaniel R Kuritzkes
The AIDS Reader|July 4, 2003
Management of patients with virologic and metabolic failureDaniel R Kuritzkes
Journal of HIV Therapy|May 8, 2003
Resistance to protease inhibitorsDaniel R Kuritzkes
Pageof 28

Showing results (1-10 of 280) with videos related to

Sort By:
Pageof 28
Current Opinion in Virology|December 14, 2011
Drug resistance in HIV-1Daniel R Kuritzkes
AIDS (London, England)|August 24, 2004
Extending antiretroviral therapy to resource-poor settings: implications for drug resistanceDaniel R Kuritzkes
Current Opinion in HIV and AIDS|April 3, 2009
HIV-1 entry inhibitors: an overviewDaniel R Kuritzkes
Journal of Medical Ethics|June 9, 2016
Why cure, why now?Daniel R Kuritzkes
The AIDS Reader|December 8, 2009
Effect of antiretroviral resistance on response in treatment-experienced patientsDaniel R Kuritzkes
Topics in HIV Medicine : a Publication of the International AIDS Society, USA|December 13, 2007
HIV resistance: frequency, testing, mechanismsDaniel R Kuritzkes
Current Opinion in HIV and AIDS|June 2, 2023
Broadly neutralizing antibodies and long-acting antiretroviral drugs as treatments for HIVDaniel R Kuritzkes
AIDS Patient Care and Stds|June 10, 2004
Preventing and managing antiretroviral drug resistanceDaniel R Kuritzkes
The AIDS Reader|July 4, 2003
Management of patients with virologic and metabolic failureDaniel R Kuritzkes
Journal of HIV Therapy|May 8, 2003
Resistance to protease inhibitorsDaniel R Kuritzkes
Pageof 28